Recombinant poxvirus expressing homologous genes inserted into the poxviral genome

Details for Australian Patent Application No. 2003236646 (hide)

Owner Bavarian Nordic A/S

Inventors Leyrer, Sonja; Howley, Paul

Agent Pizzeys

Pub. Number AU-B-2003236646

PCT Number PCT/EP03/05047

PCT Pub. Number WO2003/097846

Priority PA 2002 00752 16.05.02 DK; PA 2002 00753 16.05.02 DK

Filing date 14 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 15 January 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/285 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/07 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): PA 2002 00752 16.05.02 DK; PA 2002 00753 16.05.02 DK

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003236646

15 January 2009 Application Accepted

  Published as AU-B-2003236646

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236647-Method and apparatus for ammonia synthesis gas production.

2003236645-Method for identifying immunoreactive peptides